407 results on '"Satomi, Kaishi"'
Search Results
2. Myxoid liposarcoma with nuclear pleomorphism: a clinicopathological and molecular study
3. Age is a major determinant for poor prognosis in patients with pilocytic astrocytoma: a SEER population study
4. Implications of DNA Methylation Classification in Diagnosing Ependymoma
5. Genetic alterations that deregulate RB and PDGFRA signaling pathways drive tumor progression in IDH2-mutant astrocytoma
6. Distinct patterns of copy number alterations may predict poor outcome in central nervous system germ cell tumors
7. Pulmonary inflammatory leiomyosarcoma represents a potential diagnostic pitfall of DNA methylation-based classification of sarcomas: a case report
8. Nelarabine-induced myelopathy in patients undergoing allogeneic hematopoietic cell transplantation: a report of three cases
9. A prediction model for distant metastasis after isolated locoregional recurrence of breast cancer
10. Utility of genome-wide DNA methylation profiling for pediatric-type diffuse gliomas
11. High-grade neuroepithelial tumor with EP300::BCOR fusion and negative BCOR immunohistochemical expression: a case report
12. Utility of real-time polymerase chain reaction for the assessment of CDKN2A homozygous deletion in adult-type IDH-mutant astrocytoma
13. Inflammatory Rhabdomyoblastic Tumor: Clinicopathologic and Molecular Analysis of 13 Cases
14. Clinical significance of tumor cell seeding associated with needle biopsy in patients with breast cancer
15. Assessment of radiographic and prognostic characteristics of programmed death-ligand 1 expression in high-grade gliomas
16. Co-expression of ERG and CD31 in a subset of CIC-rearranged sarcoma: a potential diagnostic pitfall
17. The utility of DNA methylation analysis in elderly patients with pilocytic astrocytoma morphology
18. Clinical application of a highly sensitive digital PCR assay to detect a small fraction of IDH1 R132H-mutant alleles in diffuse gliomas
19. KDM2B-Rearranged Soft Tissue Sarcomas Expand the Concept of BCOR-Associated Sarcoma
20. Identification of novel SSX1 fusions in synovial sarcoma
21. Assessment of therapeutic outcome and role of reirradiation in patients with radiation-induced glioma
22. Successful Multimodal Treatment of Intracranial Growing Teratoma Syndrome with Malignant Features
23. Early progressive disease in IDH-mutant grade 2 and 3 astrocytoma without CDKN2A/B homozygous deletions may indicate radiation necrosis
24. TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma
25. Utility of methylthioadenosine phosphorylase immunohistochemical deficiency as a surrogate for CDKN2A homozygous deletion in the assessment of adult-type infiltrating astrocytoma
26. Tissue 2-Hydroxyglutarate and Preoperative Seizures in Patients With Diffuse Gliomas
27. Highly sensitive detection of TERT promoter mutations in recurrent glioblastomas using digital PCR
28. Primary spinal intramedullary Ewing-like sarcoma harboring CIC-DUX4 translocation: a similar cytological appearance as its soft tissue counterpart but no lobulation in association with desmoplastic stroma
29. Decoding the DNA methylome of central nervous system tumors: An emerging modality for integrated diagnosis.
30. Myxoid liposarcoma with nuclear pleomorphism: a clinicopathological and molecular study
31. The role of nonlinear dimension reduction of genome‐wide DNA methylome in integrated diagnosis: A case study of glioblastoma, IDH‐wildtype
32. Phenotypic characterization with somatic genome editing and gene transfer reveals the diverse oncogenicity of ependymoma fusion genes
33. A case of midbrain germinoma: A literature review for radiographic and clinical features
34. A case of "genetically defined" radiation‐induced glioma: 29 years after surgery and radiation for pilocytic astrocytoma.
35. Radiological characteristics based on isocitrate dehydrogenase mutations and 1p/19q codeletion in grade II and III gliomas
36. Supplementary Figure from HSP90 Inhibition Overcomes Resistance to Molecular Targeted Therapy in BRAFV600E-mutant High-grade Glioma
37. Supplementary Data from HSP90 Inhibition Overcomes Resistance to Molecular Targeted Therapy in BRAFV600E-mutant High-grade Glioma
38. Supplementary Table from HSP90 Inhibition Overcomes Resistance to Molecular Targeted Therapy in BRAFV600E-mutant High-grade Glioma
39. Keratin‐positive fibrotic extraskeletal myxoid chondrosarcoma: a close mimic of myoepithelial tumor
40. Local recurrence of submucosal invasive colorectal cancer after endoscopic submucosal dissection revealed by copy number variation
41. Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors
42. Bevacizumab beyond Progression for Newly Diagnosed Glioblastoma (BIOMARK): Phase II Safety, Efficacy and Biomarker Study
43. ZFTA::RELAfusion in a distinct liposarcoma morphologically overlapping with chondroid lipoma
44. Assessment of radiographic and prognostic characteristics of programmed death-ligand 1 expression in high- grade gliomas
45. DNA methylation array analysis for diffuse leptomeningeal glioneuronal tumor with conspicuous hypothalamic mass. A case report
46. Age is a major determinant for poor prognosis in patients with pilocytic astrocytoma: a SEER population study
47. Central nervous system sarcoma with ATXN1::DUX4 fusion expands the concept of CIC‐rearranged sarcoma
48. CASP9 germline mutation in a family with multiple brain tumors
49. A case of unusual histology of infantile lipoblastoma confirmed by PLAG1 rearrangement
50. Rosette-forming glioneuronal tumor originating in the hypothalamus
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.